Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
Taysha Gene Therapies, Inc. (TSHA)
Alam Kamran — CHIEF FINANCIAL OFFICER
Shares
78,968
Price
$4.75
Total Value
$375.10K
Shares Held After
1,467,635
% of Holdings
5.1%
BIODESIX INC (BDSX)
SCHULER JACK W — 10% Owner
Shares
80,000
Price
$11.81
Total Value
$944.67K
Shares Held After
1,543,210
% of Holdings
5.2%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
115,640
Price
$135.00
Total Value
$15.61M
Shares Held After
566,698
% of Holdings
16.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$40.26
Total Value
$805.11K
Shares Held After
20,000
% of Holdings
50.0%
ABBOTT LABORATORIES (ABT)
Ford Robert B — Director
Shares
18,800
Price
$107.13
Total Value
$2.01M
Shares Held After
216,203
% of Holdings
8.7%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
5,221
Price
$1.48
Total Value
$7.72K
Shares Held After
105,661
% of Holdings
4.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,151
Price
$55.98
Total Value
$64.43K
Shares Held After
449,844
% of Holdings
0.3%
Planet 13 Holdings Inc. (PLNH)
Wren Chris — VP of Operations
Shares
30,000
Price
$0.19
Total Value
$5.57K
Shares Held After
3,873,287
% of Holdings
0.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,556
Price
$5.27
Total Value
$29.28K
Shares Held After
599,603
% of Holdings
0.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
5,633
Price
$1.90
Total Value
$10.72K
Shares Held After
173,999
% of Holdings
3.1%
WEED, INC. (BUDZ)
BREEN NICOLE M — Director
Shares
38,000
Price
$0.04
Total Value
$1.60K
Shares Held After
30,413,593
% of Holdings
0.1%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
5,000,000
Price
$5.75
Total Value
$28.75M
Shares Held After
13,219,814
% of Holdings
37.8%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
8,411
Price
$1.57
Total Value
$13.24K
Shares Held After
1,166,253
% of Holdings
0.7%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
34,972
Price
$60.19
Total Value
$2.10M
Shares Held After
6,767
% of Holdings
83.8%
Sionna Therapeutics, Inc. (SION)
TPG GP A, LLC — 10% Owner
Shares
250,000
Price
$40.00
Total Value
$10.00M
Shares Held After
6,494,962
% of Holdings
3.7%
GLAUKOS Corp (GKOS)
Stapley Marc — Director
Shares
1,300
Price
$129.78
Total Value
$168.71K
Shares Held After
37,449
% of Holdings
3.4%
GLAUKOS Corp (GKOS)
Stapley Marc — Director
Shares
4,325
Price
$129.11
Total Value
$558.40K
Shares Held After
38,749
% of Holdings
10.0%
GLAUKOS Corp (GKOS)
Stapley Marc — Director
Shares
1,671
Price
$127.92
Total Value
$213.75K
Shares Held After
43,074
% of Holdings
3.7%
GLAUKOS Corp (GKOS)
Stapley Marc — Director
Shares
3,892
Price
$126.96
Total Value
$494.13K
Shares Held After
44,745
% of Holdings
8.0%
GLAUKOS Corp (GKOS)
Stapley Marc — Director
Shares
3,812
Price
$126.07
Total Value
$480.58K
Shares Held After
48,637
% of Holdings
7.3%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT & COO
Shares
3,194
Price
$129.28
Total Value
$412.92K
Shares Held After
92,366
% of Holdings
3.3%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT & COO
Shares
1,798
Price
$128.07
Total Value
$230.27K
Shares Held After
95,560
% of Holdings
1.8%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT & COO
Shares
3,100
Price
$127.03
Total Value
$393.79K
Shares Held After
97,358
% of Holdings
3.1%
GLAUKOS Corp (GKOS)
Gilliam Joseph E — PRESIDENT & COO
Shares
2,406
Price
$126.10
Total Value
$303.40K
Shares Held After
100,458
% of Holdings
2.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
12,610
Price
$5.29
Total Value
$66.66K
Shares Held After
318,619
% of Holdings
3.8%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,828
Price
$18.10
Total Value
$69.30K
Shares Held After
210,164
% of Holdings
1.8%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
1,882
Price
$18.15
Total Value
$34.16K
Shares Held After
145,355
% of Holdings
1.3%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
5,000
Price
$45.52
Total Value
$227.61K
Shares Held After
12,965
% of Holdings
27.8%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
6,198
Price
$35.00
Total Value
$216.93K
Shares Held After
34,813
% of Holdings
15.1%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
1,371
Price
$34.00
Total Value
$46.61K
Shares Held After
95,667
% of Holdings
1.4%
BIODESIX INC (BDSX)
SCHULER JACK W — 10% Owner
Shares
82,465
Price
$10.96
Total Value
$903.56K
Shares Held After
1,463,210
% of Holdings
5.6%
CEL-SCI Corporation (CVM)
KERSTEN GEERT R — Director
Shares
38,023
Price
$5.26
Total Value
$200.00K
Shares Held After
120,815
% of Holdings
31.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,500
Price
$2.95
Total Value
$7.38K
Shares Held After
0
% of Holdings
100.0%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
2,797
Price
$21.77
Total Value
$60.88K
Shares Held After
86,527
% of Holdings
3.1%
Apellis Pharmaceuticals, Inc. (APLS)
Chopas James George — VP/Chief Accounting Officer
Shares
2,064
Price
$21.77
Total Value
$44.92K
Shares Held After
49,805
% of Holdings
4.0%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
3,371
Price
$21.77
Total Value
$73.37K
Shares Held After
78,353
% of Holdings
4.1%
Apellis Pharmaceuticals, Inc. (APLS)
Deschatelets Pascal — Chief Scientific Officer
Shares
5,928
Price
$21.77
Total Value
$129.03K
Shares Held After
1,151,382
% of Holdings
0.5%
Apellis Pharmaceuticals, Inc. (APLS)
Francois Cedric — Director
Shares
27,192
Price
$21.77
Total Value
$591.84K
Shares Held After
286,045
% of Holdings
8.7%
Apellis Pharmaceuticals, Inc. (APLS)
Nicholson Nur — Chief Technical Officer
Shares
7,725
Price
$21.77
Total Value
$168.14K
Shares Held After
71,118
% of Holdings
9.8%
Apellis Pharmaceuticals, Inc. (APLS)
Sullivan Timothy Eugene — Chief Financial Officer
Shares
10,287
Price
$21.77
Total Value
$223.90K
Shares Held After
93,901
% of Holdings
9.9%
Apellis Pharmaceuticals, Inc. (APLS)
Watson David O. — General Counsel
Shares
7,832
Price
$21.77
Total Value
$170.47K
Shares Held After
88,531
% of Holdings
8.1%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
14,300
Price
$110.16
Total Value
$1.58M
Shares Held After
59,634
% of Holdings
19.3%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
12,779
Price
$46.85
Total Value
$598.75K
Shares Held After
85,660
% of Holdings
13.0%
Scholar Rock Holding Corp (SRRK)
Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Shares
2,119
Price
$45.87
Total Value
$97.19K
Shares Held After
98,439
% of Holdings
2.1%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
4,000
Price
$12.30
Total Value
$49.20K
Shares Held After
128,635
% of Holdings
3.0%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
3,977
Price
$81.34
Total Value
$323.49K
Shares Held After
22,541
% of Holdings
15.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
2,173
Price
$56.57
Total Value
$122.92K
Shares Held After
448,693
% of Holdings
0.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,665
Price
$5.32
Total Value
$67.38K
Shares Held After
605,159
% of Holdings
2.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
926
Price
$93.33
Total Value
$86.42K
Shares Held After
3,042
% of Holdings
23.3%
Mirum Pharmaceuticals, Inc. (MIRM)
Quan Joanne — CHIEF MEDICAL OFFICER
Shares
1,822
Price
$93.33
Total Value
$170.04K
Shares Held After
12,817
% of Holdings
12.4%
Showing 201–250 of 1606 transactions (page 5 of 33)